These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38615030)

  • 1. GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults.
    Cheslow L; Byrne M; Kopenhaver JS; Iacovitti L; Smeyne RJ; Snook AE; Waldman SA
    NPJ Parkinsons Dis; 2024 Apr; 10(1):83. PubMed ID: 38615030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults.
    Cheslow L; Byrne M; Kopenhaver JS; Iacovitti L; Smeyne RJ; Snook AE; Waldman SA
    Res Sq; 2023 Oct; ():. PubMed ID: 37886524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of calbindin in nigral dopaminergic neurons in two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Vidyadhara DJ; Yarreiphang H; Abhilash PL; Raju TR; Alladi PA
    J Chem Neuroanat; 2016 Oct; 76(Pt B):82-89. PubMed ID: 26775762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Chalimoniuk M; Lukacova N; Marsala J; Langfort J
    Neuroscience; 2006 Aug; 141(2):1033-1046. PubMed ID: 16716528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Wu DC; Teismann P; Tieu K; Vila M; Jackson-Lewis V; Ischiropoulos H; Przedborski S
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6145-50. PubMed ID: 12721370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.
    Sharma R; Neupane C; Pham TL; Lee M; Lee S; Lee SY; Nam MH; Kim CS; Park JB
    J Neurosci; 2023 Nov; 43(46):7730-7744. PubMed ID: 37726169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
    Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
    Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.
    Zhou JS; Zhu Z; Wu F; Zhou Y; Sheng R; Wu JC; Qin ZH
    Acta Pharmacol Sin; 2019 Feb; 40(2):180-191. PubMed ID: 29769744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
    Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels.
    Lu M; Zhao FF; Tang JJ; Su CJ; Fan Y; Ding JH; Bian JS; Hu G
    Antioxid Redox Signal; 2012 Sep; 17(6):849-59. PubMed ID: 22360462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
    L'episcopo F; Serapide MF; Tirolo C; Testa N; Caniglia S; Morale MC; Pluchino S; Marchetti B
    Mol Neurodegener; 2011 Jul; 6():49. PubMed ID: 21752258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m
    Gong X; Huang M; Chen L
    CNS Neurosci Ther; 2024 Mar; 30(3):e14441. PubMed ID: 37735974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca
    Verma A; Ravindranath V
    Front Aging Neurosci; 2019; 11():382. PubMed ID: 32009942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.
    Andrews ZB; Erion D; Beiler R; Liu ZW; Abizaid A; Zigman J; Elsworth JD; Savitt JM; DiMarchi R; Tschoep M; Roth RH; Gao XB; Horvath TL
    J Neurosci; 2009 Nov; 29(45):14057-65. PubMed ID: 19906954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.
    Cai H; Liu G; Sun L; Ding J
    Transl Neurodegener; 2014; 3():27. PubMed ID: 25705376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F; Bähr M; Dietz GP
    Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.